Healthcare Industry News: Edwards Lifesciences
News Release - February 1, 2008
Cook Inc. Sues Edwards Lifesciences Over Patent Infringement in Germany
Company asks for damages, cease and desist order against recently launched heart valve product that Cook claims infringes its patentBLOOMINGTON, Ind.--(HSMN NewsFeed)--Cook Inc. has filed suit in a Düsseldorf district court against Edwards Lifesciences Corp. of Irvine, Calif. claiming that Edwards’ Sapien THV heart valve directly infringes on German Patent DE 60128069T2. Cook is asking the court to issue a cease and desist order to prevent Edwards from manufacturing, importing, exporting, or selling the device, and has asked for an accounting of all commercial activities for the infringing product and a judgment for damages.
“We are confident that the court will uphold our patented technology upon examining the evidence presented in our complaint,” said Pete Yonkman, general counsel for Cook. “We have clearly shown that Edwards’ Sapien THV device is covered by our patent, which is one of a large portfolio of patent properties related to Cook’s development program for percutaneous valves.”
About Cook Inc.
Cook Inc. is a manufacturing division of Cook Medical, which was one of the first companies to introduce interventional devices in the United States. Today, the company integrates device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Cook is a past winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine. For more information, visit www.cookmedical.com.
Source: Cook Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
